CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 434 entries

View as:

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00257192 Org: User:

Start: 04/30/06 End: 03/31/09 Due: 03/31/10

A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00650429 Org: User:

Start: 10/31/03 End: 05/31/05 Due: 05/31/06

Patient Reported Outcomes in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT01792622 Org: User:

Start: 07/31/13 End: 09/30/13 Due: 09/30/14

A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil

Phase: N/A Priority: Normal

NCT ID: NCT00644956 Org: User:

Start: 06/30/03 End: 11/30/03 Due: 11/30/04

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

Phase: N/A Priority: Normal

NCT ID: NCT01488578 Org: User:

Start: 12/31/06 End: 03/31/11 Due: 03/31/12

A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children

Phase: N/A Priority: Normal

NCT ID: NCT00159874 Org: User:

Start: 01/31/04 End: 12/31/12 Due: 12/31/13

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study

Phase: N/A Priority: Normal

NCT ID: NCT00878943 Org: User:

Start: - End: - Due: -

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Phase: N/A Priority: Normal

NCT ID: NCT00413010 Org: User:

Start: 12/31/06 End: 03/31/08 Due: 03/31/09

Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

Phase: N/A Priority: Normal

NCT ID: NCT00137033 Org: User:

Start: 09/30/04 End: 07/31/05 Due: 07/31/06

Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity

Phase: N/A Priority: Normal

NCT ID: NCT00990223 Org: User:

Start: 10/31/09 End: 11/30/09 Due: 11/30/10

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal

NCT ID: NCT01485887 Org: User:

Start: 01/31/12 End: 01/31/14 Due: 01/31/15

Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00141232 Org: User:

Start: 11/30/04 End: 07/31/06 Due: 07/31/07

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Phase: N/A Priority: Normal

NCT ID: NCT00406315 Org: User:

Start: 11/30/06 End: 03/31/09 Due: 03/31/10

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00633438 Org: User:

Start: 01/31/04 End: 06/30/04 Due: 06/30/05

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.

Phase: N/A Priority: Normal

NCT ID: NCT01254396 Org: User:

Start: 12/31/10 End: 01/31/11 Due: 01/31/12

PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin

Phase: N/A Priority: Normal

NCT ID: NCT02273908 Org: User:

Start: 07/31/14 End: 03/31/15 Due: 03/31/16

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00312494 Org: User:

Start: 04/30/06 End: 12/31/08 Due: 12/31/09

Special Investigation Of Long Term Use Of Sertraline.

Phase: N/A Priority: Normal

NCT ID: NCT00605813 Org: User:

Start: 09/30/07 End: 09/30/11 Due: 09/30/12

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Phase: N/A Priority: Normal

NCT ID: NCT00442325 Org: User:

Start: 01/31/03 End: 02/29/04 Due: 02/28/05

GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)

Phase: N/A Priority: Normal

NCT ID: NCT00373685 Org: User:

Start: 10/31/06 End: 11/30/10 Due: 11/30/11

An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin Capsule

Phase: N/A Priority: Normal

NCT ID: NCT01009541 Org: User:

Start: 11/30/09 End: 12/31/09 Due: 12/31/10

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Phase: N/A Priority: Normal

NCT ID: NCT00277498 Org: User:

Start: 12/31/05 End: 06/30/07 Due: 06/30/08

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal

NCT ID: NCT01441440 Org: User:

Start: 11/30/11 End: 03/31/14 Due: 03/31/15

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

Phase: N/A Priority: Normal

NCT ID: NCT00150384 Org: User:

Start: 07/31/04 End: 08/31/05 Due: 08/31/06

A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia

Phase: N/A Priority: Normal

NCT ID: NCT01355068 Org: User:

Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia	NCT00257192	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-04-30	2009-03-31	2010-03-31	-	-	2025-07-14
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder	NCT00650429	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-10-31	2005-05-31	2006-05-31	-	-	2025-07-14
Patient Reported Outcomes in Pulmonary Arterial Hypertension	NCT01792622	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2013-07-31	2013-09-30	2014-09-30	-	-	2025-07-14
A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil	NCT00644956	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-06-30	2003-11-30	2004-11-30	-	-	2025-07-14
Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)	NCT01488578	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-12-31	2011-03-31	2012-03-31	-	-	2025-07-14
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children	NCT00159874	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-01-31	2012-12-31	2013-12-31	-	-	2025-07-14
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study	NCT00878943	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	-	-	-	-	-	2025-07-14
Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).	NCT00413010	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-12-31	2008-03-31	2009-03-31	-	-	2025-07-14
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population	NCT00137033	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-09-30	2005-07-31	2006-07-31	-	-	2025-07-14
Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity	NCT00990223	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-10-31	2009-11-30	2010-11-30	-	-	2025-07-14
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)	NCT01485887	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-01-31	2014-01-31	2015-01-31	-	-	2025-07-14
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes	NCT00141232	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-11-30	2006-07-31	2007-07-31	-	-	2025-07-14
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone	NCT00406315	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-11-30	2009-03-31	2010-03-31	-	-	2025-07-14
Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery	NCT00633438	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-01-31	2004-06-30	2005-06-30	-	-	2025-07-14
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.	NCT01254396	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-12-31	2011-01-31	2012-01-31	-	-	2025-07-14
PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin	NCT02273908	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2014-07-31	2015-03-31	2016-03-31	-	-	2025-07-14
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects	NCT00312494	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-04-30	2008-12-31	2009-12-31	-	-	2025-07-14
Special Investigation Of Long Term Use Of Sertraline.	NCT00605813	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-09-30	2011-09-30	2012-09-30	-	-	2025-07-14
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets	NCT00442325	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-01-31	2004-02-29	2005-02-28	-	-	2025-07-14
GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)	NCT00373685	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-10-31	2010-11-30	2011-11-30	-	-	2025-07-14
An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin Capsule	NCT01009541	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-11-30	2009-12-31	2010-12-31	-	-	2025-07-14
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma	NCT00277498	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-12-31	2007-06-30	2008-06-30	-	-	2025-07-14
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)	NCT01441440	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-11-30	2014-03-31	2015-03-31	-	-	2025-07-14
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population	NCT00150384	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-07-31	2005-08-31	2006-08-31	-	-	2025-07-14
A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia	NCT01355068	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-05-31	2011-06-30	2012-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance